HC
REGN icon

Hara Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Hara Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124K Hold
161
– – 0.06% 141
2025
Q4 		$124K Hold
161
– – 0.07% 137
2025
Q3 		$90.5K Hold
161
– – 0.05% 150
2025
Q2 		$84.5K Hold
161
– – 0.05% 173
2025
Q1 		$102K Sell
161
-159
-50% -$109K 0.07% 151
2024
Q4 		$228K Buy
320
+160
+100% +$134K 0.07% 151
2024
Q3 		$168K Buy
+160
New +$178K 0.1% 135
2024
Q1 		– Sell
-312
Closed -$274K – 140
2023
Q4 		$274K Buy
+312
New +$257K 0.19% 103

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Hara Capital's REGN Position: Q1 2026 in Review

Hara Capital held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 161 shares worth $124K. The position accounts for 0.06% of the portfolio, ranked #141.

Hara Capital first reported a position in REGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $274K in Q4 2023. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Hara Capital held 161 shares of Regeneron Pharmaceuticals worth $124K as of Q1 2026.
  • Hara Capital left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.06% of Hara Capital's portfolio in Q1 2026, its #141 holding.
  • Hara Capital first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • Hara Capital's Regeneron Pharmaceuticals position peaked at $274K in Q4 2023.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.